GSK3B and diffuse large B-cell lymphoma: In addition, PTGDS and MYH9 inhibition prevented the ubiquitination of GSK3-β and prolonged its half-life in DLBCL (Fig. 6E and F), which could induce the degradation of β-catenin and inhibit the activation of downstream molecules.